OPEN The New England journal of medicine | 13 Nov 2015
SP Sedlis, PM Hartigan, KK Teo, DJ Maron, JA Spertus, GB Mancini, W Kostuk, BR Chaitman, D Berman, JD Lorin, M Dada, WS Weintraub and WE Boden
Percutaneous coronary intervention (PCI) relieves angina in patients with stable ischemic heart disease, but clinical trials have not shown that it improves survival. Between June 1999 and January 2004, we randomly assigned 2287 patients with stable ischemic heart disease to an initial management strategy of optimal medical therapy alone (medical-therapy group) or optimal medical therapy plus PCI (PCI group) and did not find a significant difference in the rate of survival during a median follow-up of 4.6 years. We now report the rate of survival among the patients who were followed for up to 15 years.
* Data courtesy of Altmetric.com